Corporate ActionOct 30, 2026, 05:06 PM
BIO-key International Files S-1 Amendment for Warrant Resale
AI Summary
BIO-key International, Inc. has filed an Amendment No. 1 to its Form S-1 registration statement. This filing pertains to the resale of up to 1,236,668 shares of common stock by Armistice Capital Master Fund Ltd., issuable upon the exercise of warrants. The company will not receive proceeds from the sale of these shares, but expects to receive approximately $5.02 million if all warrants are exercised for cash, which will be used for working capital and general corporate purposes. The warrants have a reduced exercise price of $4.06 per share.
Key Highlights
- BIO-key International, Inc. files Amendment No. 1 to Form S-1.
- Resale of up to 1,236,668 shares of common stock issuable upon exercise of warrants.
- Selling stockholder is Armistice Capital Master Fund Ltd.
- Warrants have an exercise price of $4.06 per share.
- Gross proceeds to BIO-key from full warrant exercise estimated at $5,020,872.08.
- Company will not receive proceeds from the sale of shares by the selling stockholder.
- Common stock listed on Nasdaq Capital Market under ticker BKYI.
Price Impact
More from BKYI